<DOC>
	<DOCNO>NCT00552474</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy bilateral stimulation subthalamic nucleus ( STN ) brain use ANS Totally Implantable Deep Brain Stimulation System adjunctive treatment reduce symptom Parkinson 's Disease adequately control medication .</brief_summary>
	<brief_title>Deep Brain Stimulation Treat Symptoms Parkinson 's Disease</brief_title>
	<detailed_description>This prospective , control , multi-centered , 12 month post-implantation study . A maximum 15 site enroll total 136 patient . All study participant study device surgically implant . After implant surgery , study participant return clinic evaluation 30 day surgery , three month surgery , six month surgery twelve month surgery . At baseline , three , six twelve month visit patient 's Parkinson 's symptom ability perform daily activity evaluate use number accept assessment tool include Dyskinesia diary , evaluation PD symptom , quality life score patient extension study monitor safety efficacy ANS Libra/Libra Deep Brain Stimulation System . After 1 year study , patient may enter another protocol ( C-06-04 ) continue monitor safety efficacy Libra Deep Brain Stimulation System . Patients may follow additional 4 year . If necessary , patient may continue access investigational device protocol ( C-13-02 ) allow compassionate use access .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Person 18 80 year age Person diagnose Parkinson 's disease lease five ( 5 ) year Person experience least six ( 6 ) hour daily `` offtime '' moderate severe dyskinesia waking hour Person history improvement Parkinson 's symptom ldopa ( levodopa ) therapy Person must willing maintain constant dose antiParkinson 's disease medication least one month prior study enrollment Person must available appropriate followup time length study Person major illness medical condition would interfere participation study Person currently suffer untreated , major depression Person electrical electromagnetic implant ( e.g . cochlear prosthesis pacemaker ) Person prior surgery treatment PD symptom , include previous DBS surgery Person dementia Person history seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>Movement disorder</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Libra</keyword>
	<keyword>l-dopa</keyword>
	<keyword>levodopa</keyword>
	<keyword>neuromodulation</keyword>
	<keyword>neurostimulation</keyword>
	<keyword>Electrical stimulation brain</keyword>
	<keyword>STN</keyword>
	<keyword>Subthalamic nucleus</keyword>
</DOC>